Inhibition of lymph node metastasis by an anti-angiogenic agent, TNP-470
1997
Inhibition of Lymph Node Metastasis by TNP-470
Sample size: 20
publication
Evidence: moderate
Author Information
Author(s): Y Ohta, Y Watanabe, T Tabata, M Oda, Y Hayashi, Y Endo, M Tanaka, T Sasaki
Primary Institution: Kanazawa University
Hypothesis
Does TNP-470 inhibit lymph node metastasis in a metastatic model system using athymic nude mice?
Conclusion
TNP-470 effectively inhibits lymph node metastasis in a dose-dependent manner.
Supporting Evidence
- All mice in the no treatment group showed lymph node metastasis.
- The inhibition ratios of lymph node metastasis were 82.3% at 10 mg kg-1, 97.2% at 30 mg kg-1, and 97.5% at 100 mg kg-1.
- The treatment with TNP-470 at 100 mg kg-1 reduced the size of the primary lesion.
Takeaway
This study found that a drug called TNP-470 can help stop cancer from spreading to lymph nodes in mice.
Methodology
Athymic nude mice were injected with HT-1080 cells and treated with varying doses of TNP-470; lymph nodes were analyzed for metastasis.
Limitations
The study was conducted on mice, and results may not directly translate to humans.
Participant Demographics
Five-week-old female athymic Balb/c nude mice.
Want to read the original?
Access the complete publication on the publisher's website